Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 111 |  VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 548.05 USD | +1.44% | +8.77% | +14.33% | +38.57% | 138.91 B USD | ||
| 197 |  REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 834.04 USD | +0.90% | +4.03% | +25.93% | +41.11% | 85.87 B USD | ||
| 263 |  ARGX argenx SE - American Depositary Shares | 1039.78 USD | +0.16% | +12.13% | +13.64% | +51.67% | 64.35 B USD | ||
| 288 |  MRNA Moderna, Inc. - Common Stock | 145.13 USD | +8.86% | +125.88% | +164.64% | +435.14% | 57.94 B USD | ||
| 352 |  RVMD Revolution Medicines, Inc. - Common Stock | 209.46 USD | -1.08% | +2.67% | +10.88% | +278.09% | 44.89 B USD | ||
| 445 |  ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 236.22 USD | +3.02% | +4.63% | -13.94% | -47.90% | 31.61 B USD | ||
| 477 |  BNTX BioNTech SE - American Depositary Shares | 116.57 USD | +5.12% | +25.05% | +30.27% | +5.14% | 27.97 B USD | ||
| 484 |  INSM Insmed Incorporated - Common Stock | 125.77 USD | +0.55% | +0.85% | +17.51% | -22.39% | 27.47 B USD | ||
| 488 |  RPRX Royalty Pharma plc - Class A Ordinary Shares | 61.31 USD | +1.21% | +5.05% | +4.22% | +64.55% | 27.38 B USD | ||
| 505 |  ROIV Roivant Sciences Ltd. - Common Shares | 36.30 USD | -1.47% | +0.22% | +3.21% | +98.25% | 26.22 B USD | ||
| 508 |  INCY Incyte Corporation - Common Stock | 127.81 USD | +0.46% | +6.37% | +8.62% | +50.36% | 25.91 B USD | ||
| 575 |  UTHR United Therapeutics Corporation - Common Stock | 513.12 USD | -1.51% | +2.22% | -3.13% | +65.14% | 22.01 B USD | ||
| 676 |  JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 254.28 USD | +2.24% | +3.83% | -0.20% | +81.63% | 16.51 B USD | ||
| 687 |  BBIO BridgeBio Pharma, Inc. - Common Stock | 81.50 USD | -1.74% | +2.97% | -3.02% | +42.98% | 15.93 B USD | ||
| 696 |  ASND Ascendis Pharma A/S - American Depositary Shares | 253.29 USD | -0.60% | +2.80% | -0.89% | +23.51% | 15.70 B USD | ||
| 773 |  EXEL Exelixis, Inc. - Common Stock | 54.08 USD | +0.73% | +5.52% | -3.10% | +38.52% | 13.40 B USD | ||
| 779 |  CORT Corcept Therapeutics Incorporated - Common Stock | 122.25 USD | +0.99% | +6.30% | +33.46% | +66.62% | 13.22 B USD | ||
| 794 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 66.70 USD | -1.45% | -0.45% | +11.37% | +13.28% | 12.91 B USD | ||
| 818 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 87.11 USD | -0.41% | +0.78% | +1.30% | +122.79% | 12.30 B USD | ||
| 821 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 108.17 USD | +1.93% | +9.42% | +31.26% | +61.93% | 12.28 B USD |
Notizie Biotechnology Stocks
Il titolo di Capricor Therapeutics balza in avanti dopo la proroga della revisione FDA
FDA estende la revisione di Deramiocel di Capricor al 22 novembre
GRI Bio presenterà i dati di fase 2a sull’IPF all’ERS Congress
Alnylam presenterà dati clinici su ATTR e ipertensione all’ESC
Lexicon riceve 10 milioni di dollari da Novo Nordisk per farmaco obesità
FibroBiologics nomina Leigh Steinberg nel consiglio di amministrazione
BioCardia riceve conferma FDA sul catetere Helix
Gainers Biotechnology Stocks
 LIMN Liminatus Pharma, Inc. - Class A Common Stock | 5.15 | +4581.82% |
 SCNI Scinai Immunotherapeutics Ltd - American Depositary Shares | 3.22 | +1010.34% |
 ELAB PMGC Holdings Inc. - Common Stock | 6.66 | +991.80% |
 HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.87 | +102.33% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.55 | +38.39% |
 NTRBW Nutriband Inc. - Warrant | 0.5000 | +25.06% |
 ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 13.45 | +22.38% |
Losers Biotechnology Stocks
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0010 | -52.38% |
 OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 XCUR Exicure, Inc. - Common Stock | 1.15 | -11.54% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.39 | -11.36% |
 CURX Curanex Pharmaceuticals Inc - Common Stock | 4.71 | -10.63% |
 HURA TuHURA Biosciences, Inc. - Common Stock | 2.00 | -9.91% |